Phase 1, Open-label, Single Dose Study to Examine Safety, Tolerability, Pharmacokinetics and Virologic Impact of VRC01LS or VRC07-523LS in HIV-infected Viremic Adults
Clinical trial NCT02840474 · COMPLETED
Trial details
- NCT number
- NCT02840474
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-24
- Primary completion
- 2020-01-15
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.